Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells

Cancer Research

Volumn 66, Issue 14, 2006, Pages 7176-7184

  Nam, Jeong Seok ^a   Kang, Mi Jin ^a   Suchar, Adam M ^a   Shimamura, Takeshi ^b   Kohn, Ethan A ^a   Michalowska, Aleksandra M ^a   Jordan, V Craig ^c   Hirohashi, Setsuo ^d   Wakefield, Lalage M ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DYSADHERIN; ESTROGEN RECEPTOR; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; UVOMORULIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR CELL; UPREGULATION;

ACTINS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CHEMOKINE CCL2; ENDOTHELIAL CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NF-KAPPA B; RECEPTORS, ESTROGEN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION;

EID: 33746884603     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0825     Document Type: Article

References (53)

1. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci U S A 2002;99:365-70.
2. Sweadner KJ, Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence protein signature sequence, and expression, Genomics 2000;68:41-56.
3. Lubarski I, Pihakaski-Maunshach K, Karlish SJ, Maunshach AB, Garty H. Interaction with the Na,K-ATPase and tissue distribution of FXYD5 (related to ion channel). J Biol Chem 2005;280:37717-24.
4. Fu X, Kamps MP. F.2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIM 3T3 fibroblasts. Mol Cell Biol 1997;17:1503-12.
5. Shimamura T, Yasuda J, Ino Y, et al. Dysadherin expression facilitates cell motility und metastatic U potential of human pancreatic cancer cells. Cancel Res 2004;64:6989-95.
6. Shimamura T, Sakamoto M, Ino Y, et al. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to E-cadherin expression. J Clin Oncol 2003;21:659-67.
7. Aoki S, Shimamura T, Shibata T, et al Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer 2003;88:726-32.
8. Sato H, Ino Y, Miura A, et al. Dysadherin: expression and clinical significance in thyroid carcinoma. J Clin Endocrinol Metab 2003;88:4407-12.
9. Shimada Y, Yamasaki S, Hashimoto Y, et al. Clinical significance of dysadherin expression in gastric cancer patients. Clin Cancer Res 2004;10:2818-23.
10. Nakanishi Y, Akimoto S, Sato Y, Kanai Y, Sakamoto M, Hirohashi S. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Appl Immunohistochem Mol Morphol 2004;12:323-8.
11. Hirohashi S, Kanal Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003;94:575-81.
12. Salcedo R, Ponce ML, Young HA, et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96:34-40.
13. Tang B, Vu M, Booker T, et al. TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003;112:1116-24.
14. Jiang SY, Jordan VC. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 1992;84:580-91.
15. Shimoyama Y, Hirohashi S, Hirano S, et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 1989;49:2128-33.
16. Nam JS, Ino Y, Sakamoto M, Hirohashi S. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clin Cancer Res 2002;8:2430-6.
17. Hinck L, Nathke IS, Papkoff J, Nelson WJ. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994;125:1327-40.
18. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;1:249-64.
19. Santner SJ, Dawson PJ, Tait L, et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 2001;65:101-10.
20. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6.
21. Putti TC, El-Rehim DM, Rakha FA, et al. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol 2005;18:26-35.
22. Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004;51:55-67.
23. Wang Y, Klijn JG, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-nodenegative primary breast cancer. Lancet 2005;365:671-9.
24. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
25. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-50.
26. Rollins BJ. Monocyte chernoaUraclant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996l2:198-204.
27. Dawson TC, Kuziel WA, Osahar TA, Macda N. Absence of CC chemokine reccptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 1999;143:205-11.
28. Yamazaki D, Kurisu S, Takenawa T. Regulation of cancer cell motility through actin reorganisation. Cancer Sci 2005;96:379-86.
29. Grove M, Plumb M. C/EBP, NF-κB, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1α immediate-early gene. Mol Cell Biol 1993;13:5276-89.
30. Mestdagt M, Polette M, Buttice G, et al. Transactivation of MCP-1/CCL2 by β-catenin/TCF-4 in human breast cancer cells, Int J Cancer 2006;118:35-42.
31. Aggarwal BB. Nuclear factor-κB: the enemy within. Cancer Cell 2004;6:203-8.
32. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6.
33. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6:17-32.
34. Vaday GG, Peehl DM, Kadam PA, Lawrence DM. Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 2006;66:124-34.
35. Varney ML, Li A, Dave BJ, Bucana CD, Johansson SL, Singh RK. Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interlcukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clin Exp Metastasis 2003;20:723-31.
36. Kang H, Mansel RE, Jiang WG. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Int J Oncol 2005;26:1429-34.
37. Johrer K, Janke K, Krugmann J, Fiegl M, Greil R. Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-α via TNF receptor 2 and iuitocrine up-reguUvtion of MCP-1. Clin Cancer Res 2004;10:1901-10.
38. Conti I, Rollins BJ, CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 2004;14:149-54.
39. Huang S, Singh RK, Xie K, et al. Expression of the JE/MCP-1 gene suppresses metastatic potential in inurine colon carcinoma cells. Cancer Immunol Immunother 1994;39:231-8.
40. Monti P, Leone BR, Marchesi F, et al. The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res 2003;63:7451-61.
41. Ueno T, Toi M, Saji H, et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000;6:3282-9.
42. Saji H, Koike M, Yamori T, et al. Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 2001;92:1085-91.
43. Ohta M, Kitadai V, Tanaka S, et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol 2003;22:773-8.
44. Youngs SJ, Ali SA, Taub DD, Rees RC. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 1997;71:257-66.
45. Shin WS, Szuba A, Rockson SG. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 2002;160:91-102.
46. Chilov D, Kukk E, Taira S, et al. Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 1997;272:25176-83.
47. Ueda A, Okuda K, Ohno S, et al. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994;153:2052-63.
48. Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC. The Endocr pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 2005;12 Suppl 1:537-46.
49. Kheradmand F, Werner E, Tremble P, Symons M, Werb Z. Role of Racl and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 1998;280:898-902.
50. Crambert G, Geering K. FXYD proteins: new tissue-specific regulators of the ubiquitous Na,K-ATPase. Sci STKE 2003;2003:RE1.
51. +-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases. J Biol Chem 1998;273:15249-56.
52. +-ATPase to ERK1/2. J Biol Chem 2001;276:42050-6.
53. Brodmerkel CM, Huber R, Covington M, et al. discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist. INCB3344. Immunol 2005;175:5370-8.